


Berkshire Biomedical Corporation Revenue
Medical Equipment Manufacturing • Dallas, Texas, United States • 1-10 Employees
Berkshire Biomedical Corporation revenue & valuation
| Annual revenue | $7,340,000 |
| Revenue per employee | $1,468,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $23,500,000 |
| Total funding | No funding |
Key Contact at Berkshire Biomedical Corporation
John Timberlake
President, Chief Executive Officer and Board Member
Company overview
| Headquarters | Dallas, Texas, United States |
| Phone number | +12143891748 |
| Websites | |
| NAICS | 3391 |
| Keywords | Remote Monitoring, Drug Delivery, Personalized Medicine Delivery, Medication Delivery For Opioid User Disorder |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Berkshire Biomedical Corporation Email Formats
Berkshire Biomedical Corporation uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@berkbiomed.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@berkbiomed.com | 66.7% |
{last name}{last name} | doedoe@berkbiomed.com | 33.3% |
About Berkshire Biomedical Corporation
Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIU™). The Company’s lead product under development, the Computerized Oral Prescription Administration System (COPA™), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the Authenticated Intended User upon confirmation of dual biometric identifications (fingerprint and dentition). Upon receiving regulatory authorization, the Company intends to initially seek opportunities to leverage COPA in the delivery and remote management of oral liquid medication methadone, for Medication Use for Opioid Use Disorder treatment (MOUD) and then subsequently for the delivery of controlled medications for the treatment of pain, as they have the greatest need for the benefits of COPA’s features. The COPA™ System is currently under development, has NOT been reviewed by the U.S. Food and Drug Administration and is not available for commercial sale.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Berkshire Biomedical Corporation has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Berkshire Biomedical Corporation has never raised funding before.
Frequently asked questions
4.8
40,000 users



